Accessibility Menu
3-d Matrix logo

3-d Matrix(OTC) DMTRF

Market Cap$319.95MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2013)-95%
5 Year-15%
1 Year+262%
1 Month+11%
$2.50
+0.00%
+0.00Today
3-d Matrix last closing stock price
MetricPriceDate
Last closeUSD 2.502026-07-20
3-d Matrix stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%USD 2.502026-07-06
1 month+11.11%USD 2.252026-06-15
3 month-36.87%USD 3.962026-04-17
Year to date+5.49%USD 2.372025-12-12
1 year+262.32%USD 0.692025-03-17
3 year+125.23%USD 1.112023-07-13
5 year-14.99%USD 2.942021-07-21
Since inception-95.22%USD 52.352013-06-19

3-d Matrix Financials at a Glance

Market Cap

$319.95MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

¥10.88B

Net Income (TTM)

¥4.15B

EPS (TTM)

$0.20

P/E Ratio

11.15

Dividend

$0.00

Beta (Volatility)

-0.19 (Low)

Price

$2.50

Volume

200

Open

$2.50

Previous Close

$2.50

Daily Range

$2.50 - $2.50

52-Week Range

$0.69 - $3.96

Estimated Earnings Date

Sep 16, 2026

DMTRF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About 3-d Matrix

3-D Matrix, Ltd. is a pioneering company specializing in self-assembling peptide technology. Based in Tokyo, Japan, the firm focuses on innovative solutions for regenerative medicine, cell-based therapies, and advanced drug delivery systems.

Products and Services
  • PuraMatrix, a self-assembling peptide hydrogel
  • Applications in regenerative medicine and surgical procedures
  • Innovative drug delivery mechanisms for various therapies
Growth Outlook
  • Revenue increased to JPY 3.53 billion in Q4 2026
  • Net income reached JPY 1.80 billion, reflecting strong profitability
  • Operating income margin improved to 17.75% in Q4 2026
Financial Highlights
  • Trailing twelve months (TTM) P/E ratio stands at 9.43
  • Net profit margin of 38.17% indicates robust financial health
  • Current ratio of 3.11 suggests strong liquidity position
3-D Matrix, Ltd. has demonstrated significant growth in recent quarters, particularly in revenue and profitability. The latest quarterly results show a remarkable increase in revenue, driven by the successful adoption of PuraMatrix across various medical sectors. The company's net income and operating income margins have also shown substantial improvement, indicating effective cost management and operational efficiency. With a solid current ratio, 3-D Matrix is well-positioned to meet its short-term obligations, enhancing its appeal to potential investors. The company's innovative product offerings and strong financial performance suggest a promising future in the medical devices industry.
AI Generated • Jul 28, 2026

Industry

Biotechnology

Sector

Health Care

Employees

129

Website

www.3d-matrix.co.jp

Headquarters

Tokyo, TY 102-0083, JP

DMTRF Financials

Key Financial Metrics (TTM)

Gross Margin

78.74%

Operating Margin

12.27%

Net Income Margin

38.17%

Return on Equity

89.26%

Return on Capital

18.06%

Return on Assets

42.42%

Earnings Yield

8.97%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$319.95MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

127.98M

Volume

200

Avg. Volume

148.222

Financials (TTM)

Gross Profit

¥8.57B

Operating Income

¥1.33B

EBITDA

¥2.05B

Operating Cash Flow

¥0.00

Capital Expenditure

¥0.00

Free Cash Flow

¥0.00

Cash & ST Invst.

¥2.83B

Total Debt

¥599.04M

3-d Matrix Performance Analysis

3-d Matrix annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20232023-04-30JPY 17,010,68228.4%
20242024-04-30JPY 31,386,92884.5%
20252025-04-30JPY 45,716,65345.7%
20262026-04-30JPY 71,678,70156.8%
3-d Matrix sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12025-07-3117.0%
Q22025-10-3119.2%
Q32026-01-31-2.9%
Q42026-04-3039.3%
3-d Matrix annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20232023-04-30JPY -0.30-8.7%
20242024-04-30JPY -0.02-92.0%
20252025-04-30JPY -0.17598.3%
20262026-04-30JPY 0.20N/A
3-d Matrix sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12025-07-31155.2%
Q22025-10-3115.3%
Q32026-01-31-40.1%
Q42026-04-30225.5%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2026YOY CHG

Revenue

¥3.53B

+88.5%

Gross Profit

¥2.87B

+255.9%

Gross Margin

81.11%

N/A

Market Cap

$319.95MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$3.02M

N/A

Employees

106

N/A

Net Income

¥1.80B

+262.4%

EBITDA

¥627.41M

+157.9%

Quarterly Fundamentals

Name
Q4 2026YOY CHG

Total Cash

¥2.83B

+78.9%

Total Debt

¥599.04M

-79.6%

Accounts Receivable

¥2.68B

+39.2%

Inventory

¥3.14B

+26.1%

Long Term Debt

¥0.00

-100.0%

Short Term Debt

¥599.04M

+99.7%

Return on Assets

42.42%

N/A

Return on Invested Capital

19.52%

N/A

Free Cash Flow

¥0.00

N/A

Operating Cash Flow

¥0.00

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
EDTXFSpectral Medical Inc
$0.99-0.60%
AONCAmerican Oncology Network, Inc.
$12.00+20.00%
CMVLFCellectis S.A.
$3.47+12.66%
ABTIAlterola Biotech, Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDANvidia
$200.75+0.03%
AAPLApple
$308.91-0.07%
AMZNAmazon
$271.58+0.15%
INTCIntel
$90.20-0.01%

Questions About DMTRF

What is the current price of 3-d Matrix?

3-d Matrix is trading at $2.50 per share.

What is the 52-week range for 3-d Matrix?

Over the past 52 weeks, 3-d Matrix has traded between $0.69 and $3.96.

How much debt does 3-d Matrix have?

As of the most recent reporting period, 3-d Matrix reported total debt of ¥3.83M.

How much cash does 3-d Matrix have on hand?

3-d Matrix reported ¥18.06M in cash and cash equivalents in its most recent financial results.

What is 3-d Matrix’s dividend yield?

3-d Matrix does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services